NCT02797067View on ClinicalTrials.gov

Rectal Indomethacin to Prevent Post ESWL-pancreatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

1,370

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

August 31, 2021

Conditions
Pancreatitis
Interventions
DRUG

indomethacin suppository

100mg rectal indomethacin 30min before ESWL

DRUG

Glycerin Suppository

30min before ESWL

Trial Locations (1)

Unknown

Shanghai Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER

NCT02797067 - Rectal Indomethacin to Prevent Post ESWL-pancreatitis | Biotech Hunter | Biotech Hunter